Role of CAR-T cell K+ channels in tumor infiltration and elimination

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Chimeric antigen receptor (CAR) T-cell therapy engineers T lymphocytes to target tumor cells.
• T-lymphocyte ion channels, including Kv1.3 and KCa3.1, are crucial for T-cell function and effector responses.
• Understanding ion channel roles is vital for optimizing CAR T-cell immunotherapy.

Purpose of the Study:

• To establish and characterize CAR-engineered T-cell lines for targeting CD19-expressing tumors.
• To evaluate the efficacy of CAR T-cells in various tumor models.
• To investigate the impact of Kv1.3 and KCa3.1 ion channel inhibition on CAR T-cell anti-tumor activity.

Main Methods:

• Generated two CAR cell lines: one using CEM T-cells and another using primary T-cells, targeting the CD19 antigen.
• Assessed functional expression of KCa3.1 and Kv1.3 ion channels in CEM cells.
• Tested tumor cell killing efficiency in monolayer and 3D spheroid models.
• Administered Kv1.3 (Vm24) and KCa3.1 (TRAM34) inhibitors to evaluate their effect on tumor eradication and cell infiltration.

Main Results:

• CEM T-cells functionally expressed KCa3.1 and Kv1.3, mimicking primary T-cells.
• CAR-engineered cells effectively eliminated CD19-expressing tumor cells in both monolayer and spheroid models.
• Inhibition of Kv1.3 and KCa3.1 significantly enhanced tumor eradication in spheroids without affecting cell infiltration.

Conclusions:

• CAR T-cell therapy demonstrates specific tumor cell elimination capabilities.
• Targeting Kv1.3 and KCa3.1 ion channels represents a promising strategy to improve CAR T-cell efficacy in solid tumor immunotherapy.